Premium
COVID ‐19 and lymphangioleiomyomatosis: Experience at a reference center and the potential impact of the use of mTOR inhibitors
Author(s) -
Baldi Bruno Guedes,
Amaral Alexandre Franco,
Figueiredo Braga Colares Phillipe,
Kairalla Ronaldo Adib,
Oliveira Martina Rodrigues,
Carvalho Carlos Roberto Ribeiro
Publication year - 2020
Publication title -
american journal of medical genetics part a
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.064
H-Index - 112
eISSN - 1552-4833
pISSN - 1552-4825
DOI - 10.1002/ajmg.a.61877
Subject(s) - lymphangioleiomyomatosis , tuberous sclerosis , everolimus , medicine , sirolimus , discovery and development of mtor inhibitors , confidence interval , pi3k/akt/mtor pathway , covid-19 , retrospective cohort study , pediatrics , disease , pathology , biology , apoptosis , infectious disease (medical specialty) , biochemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom